Assignee
COMPASS PATHFINDER LTD
GB·19 granted patents·23 pending applications·159 citations·filing 2019–2025
Top patents by PatentIndex Score
42 records- 0198US11939346B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2023·Granted Mar 26, 2024·6 cites·28 claims
- 0298US11629159B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2022·Granted Apr 18, 2023·10 cites·30 claims
- 0398US11180517B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2021·Granted Nov 23, 2021·22 cites·25 claims
- 0498US11149044B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2021·Granted Oct 19, 2021·18 cites·22 claims
- 0598US10954259B1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2020·Granted Mar 23, 2021·22 cites·23 claims
- 0698US10947257B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2020·Granted Mar 16, 2021·23 cites·23 claims
- 0797US11851451B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2022·Granted Dec 26, 2023·5 cites·30 claims
- 0897US11505564B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2019·Granted Nov 22, 2022·13 cites·26 claims
- 0997US11447510B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2021·Granted Sep 20, 2022·13 cites·27 claims
- 1095US12447164B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2023·Granted Oct 21, 2025·3 cites·33 claims
- 1195US11564935B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2021·Granted Jan 31, 2023·9 cites·27 claims
- 1294US11865126B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2023·Granted Jan 9, 2024·5 cites·30 claims
- 1394US11738035B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2022·Granted Aug 29, 2023·6 cites·29 claims
- 1492US12312375B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2024·Granted May 27, 2025·0 cites·30 claims
- 1591US2025361251A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 1691US2025368665A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 1790US12433904B2Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2020·Granted Oct 7, 2025·2 cites·32 claims
- 1890US2024199660A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 1989US2025367223A1Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 2088US2025304607A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 2186US2025302851A1Methods of treating neurocognitive disorders, chronic pain and reducing inflammationCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 2284US12377112B2Methods of treating neurocognitive disorders, chronic pain and reducing inflammationCOMPASS PATHFINDER LTD·Filed 2020·Granted Aug 5, 2025·1 cites·27 claims
- 2380US11661617B2Processes for the production of tryptaminesCOMPASS PATHFINDER LTD·Filed 2020·Granted May 30, 2023·1 cites·10 claims
- 2479US12459965B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2024·Granted Nov 4, 2025·0 cites·10 claims
- 2573US12595497B2Processes for the production of tryptaminesCOMPASS PATHFINDER LTD·Filed 2023·Granted Apr 7, 2026·0 cites·11 claims
- 2667US2024269113A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 2767US2025066394A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 2866US2025066300A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl OLIGOMERIC DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 2958US2023322743A1Novel safrylamine derivatives having prodrug propertiesCOMPASS PATHFINDER LTD·Filed 2021·Application pending·0 cites
- 3058US2023295086A1Novel psilocin derivatives having prodrug propertiesCOMPASS PATHFINDER LTD·Filed 2021·Application pending·0 cites
- 3157US2023286975A1Improved method for the production of lysergic acid diethylamide (lsd) and novel derivatives thereofCOMPASS PATHFINDER LTD·Filed 2021·Application pending·0 cites
- 3256US2024197758A1Psilocybin compositions, methods of making and methods of using the sameCOMPASS PATHFINDER LTD·Filed 2022·Application pending·0 cites
- 3354US2025000881A1Treatment of treatment resistant depression with psilocybinCOMPASS PATHFINDER LTD·Filed 2022·Application pending·0 cites
- 3453US2025319095A1Use of benzodiazepines to increase sensitivity to psilocybin following a chronic ssri regimenCOMPASS PATHFINDER LTD·Filed 2021·Application pending·0 cites
- 3552US2026021070A1Subcutaneous formulations comprising psilocybin derivativesCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 3652US2025320240A1Scalable methods of manufacturing psilocybinCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 3752US2024043382A1Modified indole alkaloids for therapeutic usesCOMPASS PATHFINDER LTD·Filed 2021·Application pending·0 cites
- 3851US2024185987A1Apparatuses, systems, and methods for biomarker collection, bi-directional patient communication and longitudinal patient follow-upCOMPASS PATHFINDER LTD·Filed 2022·Application pending·0 cites
- 3949US2025352514A1Salt forms of bis(3-(2-(dimethylamino)ethyl)-1 h-indol-4-yl) 3,3'¬oxydipropionateCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 4046US2025013830A1Computing n-dimensional sentiment using a large language modelCOMPASS PATHFINDER LTD·Filed 2023·Application pending·0 cites
- 4146US2024428913A1Psilocybin therapy for treatment resistant depressionCOMPASS PATHFINDER LTD·Filed 2023·Application pending·0 cites
- 4237US2024177730A1Intelligent transcription and biomarker analysisCOMPASS PATHFINDER LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when COMPASS PATHFINDER LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →